blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1465617

EP1465617 - PROCESS FOR AFFECTING NEUROLOGIC PROGRESSION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2009
Database last updated on 11.09.2024
Most recent event   Tooltip29.10.2010Lapse of the patent in a contracting state
New state(s): GR
published on 01.12.2010  [2010/48]
Applicant(s)For all designated states
PHARMACYCLICS, INC.
995 East Arques Avenue
Sunnyvale, CA 94085-4521 / US
[2004/42]
Inventor(s)01 / MILLER, Richard, A.
250 Golden Hills Drive
Portola Valley, CA 94028 / US
 [2004/42]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Rothenbaumchaussee 58
20148 Hamburg / DE
[N/P]
Former [2004/42]Glawe, Delfs, Moll & Partner
Patentanwälte Rothenbaumchaussee 58
20148 Hamburg / DE
Application number, filing date02799240.312.12.2002
[2004/42]
WO2002US39974
Priority number, dateUS20010339650P13.12.2001         Original published format: US 339650 P
US20020346584P07.01.2002         Original published format: US 346584 P
US20020353090P30.01.2002         Original published format: US 353090 P
[2004/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03049731
Date:19.06.2003
Language:EN
[2003/25]
Type: A1 Application with search report 
No.:EP1465617
Date:13.10.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 19.06.2003 takes the place of the publication of the European patent application.
[2004/42]
Type: B1 Patent specification 
No.:EP1465617
Date:15.10.2008
Language:EN
[2008/42]
Search report(s)International search report - published on:US19.06.2003
(Supplementary) European search report - dispatched on:EP30.08.2005
ClassificationIPC:A61K31/33, A61P25/00
[2008/11]
CPC:
A61K31/555 (EP,KR,US); A61K31/33 (KR); A61K47/546 (EP,US);
A61K47/60 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P35/00 (EP); A61P35/02 (EP) (-)
Former IPC [2004/42]A61K31/33
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/42]
Extension statesAL09.07.2004
LT09.07.2004
LV09.07.2004
MK09.07.2004
RO09.07.2004
TitleGerman:VERFAHREN ZUR BEEINFLUSSUNG NEUROLOGISCHER PROGRESSION[2004/42]
English:PROCESS FOR AFFECTING NEUROLOGIC PROGRESSION[2004/42]
French:PROCEDE PERMETTANT D'AFFECTER LA PROGRESSION NEUROLOGIQUE[2004/42]
Entry into regional phase09.07.2004National basic fee paid 
09.07.2004Search fee paid 
09.07.2004Designation fee(s) paid 
09.07.2004Examination fee paid 
Examination procedure11.07.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
09.07.2004Amendment by applicant (claims and/or description)
09.07.2004Examination requested  [2004/42]
07.04.2006Despatch of a communication from the examining division (Time limit: M04)
01.08.2006Reply to a communication from the examining division
12.12.2006Despatch of a communication from the examining division (Time limit: M04)
16.03.2007Reply to a communication from the examining division
09.05.2008Communication of intention to grant the patent
27.08.2008Fee for grant paid
27.08.2008Fee for publishing/printing paid
Opposition(s)16.07.2009No opposition filed within time limit [2009/39]
Fees paidRenewal fee
23.12.2004Renewal fee patent year 03
27.12.2005Renewal fee patent year 04
27.12.2006Renewal fee patent year 05
24.12.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY15.10.2008
CZ15.10.2008
EE15.10.2008
FI15.10.2008
SI15.10.2008
SK15.10.2008
TR15.10.2008
BG15.01.2009
GR16.01.2009
[2010/48]
Former [2010/37]CY15.10.2008
CZ15.10.2008
EE15.10.2008
FI15.10.2008
SI15.10.2008
SK15.10.2008
TR15.10.2008
BG15.01.2009
Former [2010/34]CY15.10.2008
CZ15.10.2008
EE15.10.2008
FI15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
Former [2009/43]CZ15.10.2008
EE15.10.2008
FI15.10.2008
SI15.10.2008
SK15.10.2008
BG15.01.2009
Former [2009/39]CZ15.10.2008
EE15.10.2008
FI15.10.2008
SI15.10.2008
BG15.01.2009
Former [2009/36]EE15.10.2008
FI15.10.2008
SI15.10.2008
BG15.01.2009
Former [2009/25]FI15.10.2008
SI15.10.2008
BG15.01.2009
Former [2009/23]BG15.01.2009
Documents cited:Search[DA]  - JULIETTE VIALA AND ALL., "Phase IB and II multidose trial of Gadolinium Texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases", RADIOLOGY, (1999), vol. 212, pages 755 - 759, XP002341426 [DA] * abstract *
 [A]  - DAVID I. ROSENTHAL AND ALL., "A phase I single-dose trial of Gadolinium Texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging", CLINICAL CANCER RESEARCH, (199904), vol. 5, pages 739 - 745, XP002341427 [A] * abstract *
 [A]  - ERIC J. BERNHARD AND ALL., "Re-evaluating Gadolinium(III) Texaphyrin as a radiosensitizing agent", CANCER RESEARCH, (200001), vol. 60, pages 86 - 91, XP002341428 [A] * abstract *
International search[A]US5569759  (SESSLER JONATHAN L [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.